CBD Oil for Depression, Schizophrenia,
ADHD, PTSD, Anxiety.
More than 70 different components can be extracted from a marijuana plant, technically known as cannabis sativa. Two of them are cannabidiol (CBD) and tetrahydrocannabinol (THC). Since CBD does not cause you to get ‘high’ as compared to THC, it is increasingly marketed as a cure for all ailments. You can find CBD products online to treat problems like back pain, anxiety, sleep problems, and mental health concerns.
CBD is very effective in treating mentaldisorder symptoms, and has no negative effects of tolerance or withdrawal, unlike THC. CBD is derived from the cannabis plant, and shouldn’t be confused with synthetic cannabinoid receptor agonists like K2 or spice.
Since it is more relaxed legally, CBD has been widely studied by researchers for both animals as well as humans. As researchers Campos et al. (2016) noted, “The investigation of the possible positive impact of CBD in neuropsychiatric disorders began in the 1970s. After a slow progress, this subject has been showing an exponential growth in the last decade.”
According to research, CBD Oil has been effective in curing many health conditions. It is known to treat glaucoma, epilepsy, pain, inflammation, multiple sclerosis, Parkinson’s disease, Huntington’s disease, and Alzheimer’s. It also helps people with gut diseases, like gastric ulcers, Crohn’s disease, and irritable bowel syndrome.
In a pilot randomized placebo-controlled study of adults with attention deficit hyperactivity disorder (ADHD), a positive effect was only found on the measurements of hyperactivity and impulsivity, but not on the measurement of attention and cognitive performance.
The treatment used 1:1 ratio of CBD and THC, one of the common CBD treatments being studied along with CBD oil on its own. The finding suggests CBD oil needs more research on cure for people with ADHD.
Studies show that CBD reduces self-reportedanxiety and sympathetic arousal in those people without a mental disorder. Research also shows it may reduce anxiety that was artificially induced in an experiment with patients suffering from social phobia, according to Loflin et al. (2017).
Loflin et al. (2017) only found a single CBD study conducted on sleep quality:
Specifically, 40, 80, and 160 mg CBD capsules were administered to 15 individuals with insomnia. Results suggested that 160 mg CBD was associated with an overall improvement in self-reported sleep quality.
Compared to the general population, individuals with schizophrenia are twice as likely to use cannabis. This worsens their condition and psychotic symptoms. It can also increase relapse and result in poorer treatment outcomes (Osborne et al., 2017).
In a review of CBD research to date on its impact on schizophrenia, Osborne and associates (2017) found:
In conclusion, the studies presented in the current review demonstrate that CBD has the potential to limit delta-9-THC-induced cognitive impairment and improve cognitive function in various pathological conditions.
Human studies suggest that CBD may have a protective role in delta-9-THC-induced cognitive impairments; however, there is limited human evidence for CBD treatment effects in pathological states (e.g. schizophrenia).
Basically, they found CBD to help alleviate the negative impact of a person suffering from Schizophrenia from taking cannabis,both in the psychotic and cognitive symptoms associated with schizophrenia.